Celik A, Berg T, Gibson M, Jensen M-B, Kümler I, Eßer-Naumann S, et al. Capecitabine monotherapy as first-line treatment in advanced HER2-normal breast cancer – a nationwide, retrospective study. AO [Internet]. 2024 Jun. 23 [cited 2024 Nov. 21];63(1):494-502. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/38886